Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective

Published:2020-07-15 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Zhang Li,Zhang Jiang-Tao,Hang Lihua,Liu Tong

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference78 articles.

1. Opioid therapy for chronic pain;Ballantyne;New Engl. J. Med.,2003

2. Cellular and molecular mechanisms of pain;Basbaum;Cell,2009

3. The Public and the Opioid-Abuse Epidemic;Blendon;New Engl. J. Med.,2018

4. Cannabinoids in the descending pain modulatory circuit: Role in inflammation;Bouchet;Pharmacol. Ther.,2020

5. Monoaminergic control of the release of calcitonin gene-related peptide- and substance P-like materials from rat spinal cord slices;Bourgoin;Neuropharmacology,1993

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intrathecal administration of MCRT produced potent antinociception in chronic inflammatory pain models via μ-δ heterodimer with limited side effects;Biomedicine & Pharmacotherapy;2024-10

2. Delta opioid receptors engage multiple signaling cascades to differentially modulate prefrontal GABA release with input and target specificity;2024-08-09

3. Bivalent and bitopic ligands of the opioid receptors: The prospects of a dual approach;Medicinal Research Reviews;2024-05-15

4. Fentanyl and its derivatives: Pain-killers or man-killers?;Heliyon;2024-04

5. Evidence for heterodimerization and functional interaction of the urotensin II and the angiotensin II type 1 receptors;Cellular Signalling;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3